Search

You searched for "diagnostic"

546 results found

COVID-19 cuts prostate cancer referrals in half

7 October 2020 | URO - Urologic Oncology
Charity warns that 3500 men risk being diagnosed with incurable cancer as referrals drop to lowest in 10 years Urgent referrals for urological cancers have dropped by half in England (49.5%) compared to the same period last year as the...

Tackle Prostate Cancer: Make Sense of It Programme

7 January 2026
Tackle Prostate Cancer is a small national charity with a big reach. We exist to ensure that people living with and affected by prostate cancer are not left to navigate diagnosis, treatment decisions and life after treatment on their own....

MAPLe – the pelvic floor in high definition. One probe, all dysfunctions

11 July 2022 | Research & Development
The MAPLe high-definition technology enables you to diagnose and view a patient’s individual pelvic floor muscle EMG activity at a glance, making it possible for you to provide a more...

Focal therapy trials

6 November 2020 | | URO - Urologic Oncology
Men with localised prostate cancer have traditionally required whole gland treatment involving radical prostatectomy or radical radiation treatment, independent of disease location and size. Increasing evidence supports the use of active treatment only in those men diagnosed with prostate cancer...
Interventional Urology book cover image.

Cord compression in cancer

1 September 2016 | | URO - Urologic Oncology
This article will be of great interest to uro-oncologists. Vertebral metastasis occurs in 3-5% of all cancers (most commonly in prostate, breast and lung cancer). It can cause pain, vertebral collapse and cord compression. Data from the National Institute for...

Action Bladder Cancer UK urges health professionals to help raise awareness during Bladder Cancer Awareness Month in May

28 March 2025 | Company Profiles, Research & Development, Charities
Action Bladder Cancer UK is calling on health professionals – including specialist urology and cancer nurses, urologists, oncology and radiology health professionals and others, to support Bladder Cancer Awareness Month by helping to raise awareness of the symptoms of bladder...

Prostate Scotland launches updated resource to support men considering active surveillance for early prostate cancer

15 April 2026 | Urology News, Charities
Prostate Scotland has launched an updated patient information booklet focusing on active surveillance. The resource is designed for men newly diagnosed with localised prostate cancer, helping them to understand active surveillance as a management option and supporting informed discussions with...

I wasn’t expecting that! A series of unexpected radiology findings

1 July 2017 | URO - Uroradiology
Case 1 A 76-year-old diabetic man with a long-term catheter presents to the Emergency Department with rigors and non-specific abdominal pain. He has an elevated white cell count (WCC) and C-reactive protein (CRP). An abdominal and pelvic CT scan was...

What’s new in post prostatectomy incontinence?

1 January 2017 | | URO - Functional / Reconstructive Urology
With an ageing population, the number of men being diagnosed with prostate cancer each year is steadily rising. With more specific investigations, such as multiparametric magnetic resonance imaging (MpMRI) and transperineal biopsies, the number of cases diagnosed at an earlier...

Metastatic spinal cord compression – a review

1 March 2014 | | URO - Trauma & Emergency, URO - Urologic Oncology
Introduction Metastatic spinal cord compression (MSCC) is an oncological emergency that, unless diagnosed early and treated appropriately, can lead to significant morbidity and mortality, including paralysis and bladder and bowel dysfunction. MSCC can be defined as spinal cord or cauda...

Grant Stott challenges Scottish men to talk about prostate cancer this March

3 March 2026
Broadcaster and actor Grant Stott is urging men across Scotland to start a simple but potentially life-saving conversation this Prostate Cancer Awareness Month. Grant, 58, recently had his first prostate-specific antigen (PSA) test after being inspired by Sir Chris Hoy...

Improving on the Rotterdam Prostate Cancer Risk Calculator

1 January 2019 | | URO - Technology
Following the PROMIS trial [1], many cancer centres in the UK are now offering pre-biopsy multiparametric MRI (mpMRI) for men suitable for radical treatment. The European Association of Urology for Prostate Cancer (PCa) guidelines recommend individual risk stratification before the...